Publications by Anna Isotta Castrini
20 publications found
Original articles
Prediction of severe ventricular arrhythmias in mitral valve prolapse patients by exercise ECG
Heart Rhythm (in press)
DOI 10.1016/j.hrthm.2024.04.076, PubMed 38663787
The added value of abnormal regional myocardial function for risk prediction in arrhythmogenic right ventricular cardiomyopathy
Eur Heart J Cardiovasc Imaging, 24 (12), 1710-1718
DOI 10.1093/ehjci/jead174, PubMed 37474315
Monitoring of Myocardial Involvement in Early Arrhythmogenic Right Ventricular Cardiomyopathy Across the Age Spectrum
J Am Coll Cardiol, 82 (9), 785-797
DOI 10.1016/j.jacc.2023.05.065, PubMed 37612010
Pregnancy and Progression of Cardiomyopathy in Women With LMNA Genotype-Positive
J Am Heart Assoc, 11 (8), e024960
DOI 10.1161/JAHA.121.024960, PubMed 35434999
Progression of cardiac disease in patients with lamin A/C mutations
Eur Heart J Cardiovasc Imaging, 23 (4), 543-550
DOI 10.1093/ehjci/jeab057, PubMed 33824984
The response to cardiac resynchronization therapy in LMNA cardiomyopathy
Eur J Heart Fail, 24 (4), 685-693
DOI 10.1002/ejhf.2463, PubMed 35229420
Sex differences in disease progression and arrhythmic risk in patients with arrhythmogenic cardiomyopathy
Europace, 23 (7), 1084-1091
DOI 10.1093/europace/euab077, PubMed 33829244
Pregnancies, ventricular arrhythmias, and substrate progression in women with arrhythmogenic right ventricular cardiomyopathy in the Nordic ARVC Registry
Europace, 22 (12), 1873-1879
DOI 10.1093/europace/euaa136, PubMed 32681178
Absence of ECG Task Force Criteria does not rule out structural changes in genotype positive ARVC patients
Int J Cardiol, 317, 152-158
DOI 10.1016/j.ijcard.2020.05.095, PubMed 32504717
Number of pregnancies and subsequent phenotype in a cross-sectional cohort of women with arrhythmogenic cardiomyopathy
Eur Heart J Cardiovasc Imaging, 20 (2), 192-198
DOI 10.1093/ehjci/jey061, PubMed 29659777
Prognostic value of the absolute lymphocyte count in patients admitted for acute heart failure
J Cardiovasc Med (Hagerstown), 18 (11), 859-865
DOI 10.2459/JCM.0000000000000428, PubMed 27541359
N-terminal pro-B-type natriuretic peptide-guided therapy in patients hospitalized for acute heart failure
J Cardiovasc Med (Hagerstown), 17 (11), 828-39
DOI 10.2459/JCM.0000000000000419, PubMed 27322401
Prognostic value of serial measurements of blood urea nitrogen in ambulatory patients with chronic heart failure
Panminerva Med, 58 (1), 8-15
PubMed 26154625
Effects of oral administration of orodispersible levo-carnosine on quality of life and exercise performance in patients with chronic heart failure
Nutrition, 31 (1), 72-8
DOI 10.1016/j.nut.2014.04.021, PubMed 25287762
[Efficacy of ACE-inhibitors in patients with recent myocardial infarction. Studies with zofenopril]
G Ital Cardiol (Rome), 13 (10 Suppl 2), 55S-58S
DOI 10.1714/1167.12922, PubMed 23096377
Review articles
Serelaxin a novel treatment for acute heart failure
Expert Rev Clin Pharmacol, 8 (5), 549-57
DOI 10.1586/17512433.2015.1073587, PubMed 26294074
Amino acids and derivatives, a new treatment of chronic heart failure?
Heart Fail Rev, 20 (1), 39-51
DOI 10.1007/s10741-014-9436-9, PubMed 24925377
Other articles
Lifetime exercise dose and ventricular arrhythmias in patients with mitral valve prolapse
Europace, 25 (10)
DOI 10.1093/europace/euad309, PubMed 37851515
Sudden cardiac death in the young-Can illicit drug use explain the unexplained?
Heart Rhythm, 20 (10), 1356-1357
DOI 10.1016/j.hrthm.2023.06.014, PubMed 37352948
Reply to: TFC ECG in arrhythmogenic cardiomyopathy: Inadequate mixture of criteria?
Int J Cardiol, 323, 203
DOI 10.1016/j.ijcard.2020.08.050, PubMed 32810539